Searchable abstracts of presentations at key conferences in endocrinology

ea0015s42 | Recent advances and new treatment options in diabetes | SFEBES2008

Immune therapy: prevention is better than cure

Roep Bart

Type 1 diabetes (T1D) is a T-cell mediated autoimmune disease in which the insulin-producing pancreatic beta-cells in the islets of Langerhans are destroyed. While the symptoms of the disease have become treatable to a certain extent, even intensive state-of-the-art insulin therapy cannot prevent the development of severe complications in the majority of patients. There is, therefore, a huge and unmet clinical demand for disease intervention, but a cure for T1D does not yet ex...

ea0084op-13-65 | Oral Session 13: Basic 3 | ETA2022

3,3’,5-triiodo-l-thyronine and 3,5-diodo-l-thyronine differentially modulate hepatic mitochondrial quality control in hypothyroid rats

Giacco Antonia , Petito Giuseppe , Mercurio Giovanna , Magnacca Nunzia , Senese Rosalba , Silvestri Elena , Cioffi Federica

Objective: The maintenance of healthy and functional mitochondrial network via mitochondrial quality control (QC) mechanisms, is critical throughout life to respond to physiological adaptations and stress. Due to their role in energy production, mitochondria are exposed to high amounts of reactive oxygen species making their DNA (mtDNA) particularly vulnerable to oxidative damage. Mitochondrial dysfunction causes altered QC mechanisms (i.e. altered biogenesis, dynamics, autoph...

ea0006p53 | Bone | SFE2003

VITAMIN D INSUFFICIENCY AND PLASMA LEVELS OF sRANK-L and OPG IN OSTEOPOROTIC WOMEN

Jabbar S , Drury J , Varey J

The TNF members sRANK-L & Osteoprotegerin (OPG) are essential paracrine mediators of osteoclast function in vitro. The aim of this study was to establish the relationship between 25-hydroxyvitamin D and sRANK-L and OPG in plasma of osteoporotic patients.The study population consisted of 185 osteoporotic women (mean age 62.4 years), with bone mineral density (BMD) more than 2.5 SD below the young adult value, and 185 age-matched controls, with normal ...

ea0018p31 | (1) | MES2008

Diagnostic cut-off for calcitonin: is 10 ng/l still valid?

Ramachandran Radha , Benfield Patricia , White Sara , Chapman Richard , Meeran Karim , Donaldson Mandy , Martin Niamh

Aim: Population studies have shown that basal calcitonin concentrations are below 10 ng/l in the normal population. Ten nanograms per liter is used as a diagnostic cut-off by most laboratories and patients with levels higher than this are offered a pentagastrin stimulation test to exclude medullary thyroid carcinoma. However, these guidelines were adopted from studies that used the Cisbio Immunoradiometric assay for measuring calcitonin. Most laboratories have now moved to che...

ea0012p133 | Thyroid | SFE2006

Does L-thyroxine reduce weight in people with subclinical hypothyroidism?

Razvi S , Pearce SH , Weaver JU

ObjectiveIt is controversial whether subclinical hypothyroidism (SCH) always reflects mild thyroid failure and if treatment is beneficial. The arguments in favour of treatment are prevention of progression, reducing cholesterol levels and improving symptoms. The consequence of SCH on body weight and its response to treatment has never been studied in a systematic manner.MethodsUnselected population-based stud...

ea0056gp111 | Diabetes Translational | ECE2018

Olfactory receptor OR51E1 mediates GLP-1 secretion in enteroendocrine L cells

Ku Cheol Ryong , Han Ye Eon , Kim Daham , Hong Jae Won , Kim Sun Ho , Lee Eun Jig

Few studies have investigated the intracellular signaling pathways mediating the effects of glucagon-like peptide-1 (GLP-1) secretagogues in enteroendocrine L cells. Specific receptors, channels, and intracellular signaling proteins expressed by the L cells have only begun to be characterized. The present study aimed to investigate the role of the olfactory receptor (OR) OR51E1 in GLP-1 secretion. We verified the expression of olfactory marker protein (OMP), an indicator of OR...

ea0006p54 | Bone | SFE2003

sRANK-L AND OPG CORRELATE WITH BONE MINERAL DENSITY IN OSTEOPOROSIS

Jabbar S , Drury J , Varey J

The Osteoprotegerin (OPG) RANK and RANK-L system is a novel paracrine system that forms part of the mechanism of bone turnover. The aim of this study was to explore if the OPG/ RANK-L system, detectable in blood, is related to bone mineral density.The study population consisted of 185 osteoporotic women (mean age 62.4 years), with bone mineral density (BMD) more than 2.5 SD below the young adult value, and 185 age-matched controls, with normal bone miner...

ea0038p189 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2015

The effect of L-arginine on anorectic gut hormone release in humans

Amin Anjali , Neophytou Christina , Murphy Kevin

High protein diets suppress appetite and facilitate weight loss, but are difficult to adhere to in the long-term. Understanding the mechanisms by which protein suppresses appetite may establish targets for more acceptable interventions to treat or prevent obesity. Of particular interest is the concept of functional foods or novel products which aim to potentiate satiety. However, the specific mechanisms regulating protein-induced satiety are unknown. Protein has a satiating ef...

ea0025p237 | Pituitary | SFEBES2011

Molecular and functional characterisation of an endocannabinoid system in LβT2 gonadotrophs

Smith Lorna , Davies Elizabeth , Gastaldello Annalisa , Thompson Iain , Perello Edward , Korbonits Marta , Campanella Michelangelo , Fowkes Robert

Cannabinoids are known to exert effects throughout the endocrine system, including in the anterior pituitary. Whilst cannabinoid receptors (CB1 in particular) are expressed in numerous tissues, expression and function of an endocannabinoid system within specific anterior cell types has not been investigated. We have used well-characterised gonadotroph (LβT2 and αT3-1) and somatolactotroph (GH3) cell lines to establish the expression and functional role for cannabinoi...

ea0041ep1083 | Thyroid (non-cancer) | ECE2016

The beneficial effect of L-thyroxine on lipid parameters in mild form of subclinical hypothyroidism

Nakova Valentina Velkoska , Krstevska Brankica , Pemovska Gordana , Milenkovikj Tatjana , Vaskova Olivija

Introduction: Overt hypothyroidism and severe subclinical hypothyroidism (ScH) are associated with dyslipidaemia, and its condition is reversible after thyroid replacement therapy. We investigated the effect of levothyroxine therapy on lipid parameters in patients with mild form of subclinical hypothyroidism (ScH).Material and methods: Fifty-seven patients with newly diagnosed ScH with TSH levels below 10 mU/l and 30 age and sex-matched healthy subjects ...